Survey reveals less than half of Americans plan to get flu shot this season
A survey conducted by the National Foundation for Infectious Diseases (NFID) revealed that only 49 percent of polled U.S. adults plan to get a flu shot this season, CNBC reports.
The data shows that 1 in 5 respondents at higher risk for influenza-related complications reported that they do not plan to get the annual vaccine this season. People over 65 years old, pregnant people, patients with underlying conditions, and children under five face a significant risk of severe outcomes if infected with the flu, per the Centers for Disease Control and Prevention.
The NFID survey found that while nearly 70 percent of people agreed that the annual flu shot was the best way to prevent fatal influenza infections, many are still electing not to get the vaccine this year. CNBC reports that 58 percent of the Americans surveyed plan to wear masks at least part of the time to protect themselves during flu season, which exceeds the number who plan to get the shot.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Per the NFID survey, some of the top reasons for not getting the vaccine include believing that the flu shot is ineffective and concerns over potential side effects.
"With COVID, people have forgotten about influenza," said William Schaffner, medical director of NFID, at an NFID conference on Tuesday. "This is another serious winter respiratory virus, it can do bad damage to you. The key to prevention is vaccination."
The survey polled 1,005 adult respondents throughout the United States and was conducted via phone and web between Aug. 11 and 15. The overall margin of error is +/- 4.2 percentage points.
Create an account with the same email registered to your subscription to unlock access.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Theara Coleman has worked as a staff writer at The Week since September 2022. She frequently writes about technology, education, literature and general news. She was previously a contributing writer and assistant editor at Honeysuckle Magazine, where she covered racial politics and cannabis industry news.
-
What to know when planning an awe-inspiring hike on the Inca Trail
The Week Recommends Peru's most famous trail leads to Machu Picchu
By Catherine Garcia, The Week US Published
-
Lead poisoning remains a threat
The Explainer The toxin is built into our lives
By Devika Rao, The Week US Published
-
Should you use a 529 plan? What to know about this college savings option.
The Explainer This tax-advantaged savings account can be used to pay tuition or buy textbooks
By Becca Stanek, The Week US Published
-
Lead poisoning remains a threat
The Explainer The toxin is built into our lives
By Devika Rao, The Week US Published
-
Texas dairy worker gets bird flu from infected cow
Speed Read The virus has been spreading among cattle in Texas, Kansas, Michigan and New Mexico
By Peter Weber, The Week US Published
-
Dengue hits the Americas hard and early
Speed Read Puerto Rico has declared an epidemic as dengue cases surge
By Peter Weber, The Week US Published
-
The alarming rise of cancer in young people
Under the radar Cancer rates are rising, and the cause is not clear
By Devika Rao, The Week US Published
-
US bans final type of asbestos
Speed Read Exposure to asbestos causes about 40,000 deaths in the U.S. each year
By Peter Weber, The Week US Published
-
Narcan is becoming harder to find at drugstores across America
Under the Radar The drug, also known as naloxone, reverses the effects of an opioid overdose
By Justin Klawans, The Week US Published
-
The lows of an unregulated high: Teens are using marijuana alternative delta-8
In the Spotlight More than 1 in 10 high school seniors have reported using the substance, which contains concentrated THC
By Justin Klawans, The Week US Published
-
OTC birth control arrives amid the battle over reproductive rights
Talking Points Opill will cost $19.99 a month. Democrats are pushing to make it cheaper.
By Joel Mathis, The Week US Published